BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35600344)

  • 1. Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research.
    Janssens E; Mol Z; Vandermeersch L; Lagniau S; Vermaelen KY; van Meerbeeck JP; Walgraeve C; Marcq E; Lamote K
    Front Oncol; 2022; 12():851785. PubMed ID: 35600344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways.
    Di Gilio A; Catino A; Lombardi A; Palmisani J; Facchini L; Mongelli T; Varesano N; Bellotti R; Galetta D; de Gennaro G; Tangaro S
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study.
    Lamote K; Brinkman P; Vandermeersch L; Vynck M; Sterk PJ; Van Langenhove H; Thas O; Van Cleemput J; Nackaerts K; van Meerbeeck JP
    Oncotarget; 2017 Oct; 8(53):91593-91602. PubMed ID: 29207669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS).
    Lamote K; Vynck M; Van Cleemput J; Thas O; Nackaerts K; van Meerbeeck JP
    J Breath Res; 2016 Sep; 10(4):046001. PubMed ID: 27669062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled Breath Analysis in Diagnosis of Malignant Pleural Mesothelioma: Systematic Review.
    Töreyin ZN; Ghosh M; Göksel Ö; Göksel T; Godderis L
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32050546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review.
    Brusselmans L; Arnouts L; Millevert C; Vandersnickt J; van Meerbeeck JP; Lamote K
    Transl Lung Cancer Res; 2018 Oct; 7(5):520-536. PubMed ID: 30450290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled breath to screen for malignant pleural mesothelioma: a validation study.
    Lamote K; Vynck M; Thas O; Van Cleemput J; Nackaerts K; van Meerbeeck JP
    Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29269578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma.
    Janssens E; Schillebeeckx E; Zwijsen K; Raskin J; Van Cleemput J; Surmont VF; Nackaerts K; Marcq E; van Meerbeeck JP; Lamote K
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure.
    de Gennaro G; Dragonieri S; Longobardi F; Musti M; Stallone G; Trizio L; Tutino M
    Anal Bioanal Chem; 2010 Dec; 398(7-8):3043-50. PubMed ID: 20924566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
    Rodrigues D; Pinto J; Araújo AM; Monteiro-Reis S; Jerónimo C; Henrique R; de Lourdes Bastos M; de Pinho PG; Carvalho M
    Metabolomics; 2018 Apr; 14(5):62. PubMed ID: 30830384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breath Analysis: A Systematic Review of Volatile Organic Compounds (VOCs) in Diagnostic and Therapeutic Management of Pleural Mesothelioma.
    Catino A; de Gennaro G; Di Gilio A; Facchini L; Galetta D; Palmisani J; Porcelli F; Varesano N
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31207975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Headspace analysis of mesothelioma cell lines differentiates biphasic and epithelioid sub-types.
    Little LD; Carolan VA; Allen KE; Cole LM; Haywood-Small SL
    J Breath Res; 2020 Sep; 14(4):046011. PubMed ID: 32731209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic review.
    Janssens E; van Meerbeeck JP; Lamote K
    Crit Rev Oncol Hematol; 2020 Sep; 153():103037. PubMed ID: 32771940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
    Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
    Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF-
    Hayton C; Ahmed W; Cunningham P; Piper-Hanley K; Pearmain L; Chaudhuri N; Leonard C; Blaikley JF; Fowler SJ
    J Breath Res; 2023 Sep; 17(4):. PubMed ID: 37619557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls.
    Dragonieri S; van der Schee MP; Massaro T; Schiavulli N; Brinkman P; Pinca A; Carratú P; Spanevello A; Resta O; Musti M; Sterk PJ
    Lung Cancer; 2012 Mar; 75(3):326-31. PubMed ID: 21924516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.
    Thomas A; Karakattu S; Cagle J; Hoskere G
    Cureus; 2021 Apr; 13(4):e14605. PubMed ID: 34040906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.